Surgical and Medical Innovations in Lung and Respiratory Health
Presented by New England Healthcare Executive Network
Foley Hoag LLP
155 Seaport Boulevard
Boston, MA 02210-2600
The Lung Center at Brigham and Women's Hospital provides comprehensive care for lung patients. Our keynote speaker is Dr. Raphael Bueno, Division Chief of Thoracic Surgery at the Brigham. Dr. Bueno's primary research involves the development of novel translational tools in genomics that can be used to identify candidate predictive and diagnostic markers for cancer, as well as novel targets for therapy, specifically mesothelioma and lung cancer. He will share his experiences and development of Image-guided Video Assisted Thoracoscopic Surgery (iVATS) technology for minimally invasive identification and removal of early stage lung tumors and other soft tissue cancers.
Come join this timely, keynote presentation and blue-ribbon panel of experts as they discuss patient management and innovations in thoracic surgery. Ask them questions and contribute your insights during the audience interactive segment. Identify potential new businesses opportunities in lung and respiratory health.
Raphael Bueno, M.D., Chief, Division of Thoracic Surgery, Co-Director, Brigham and Women's Lung Center, Vice Chairman of Surgery for Cancer and Translational Research, Fredric G. Levin Distinguished Chair in Thoracic Surgery and Lung Cancer Research, Professor, Harvard Medical School
As Chief of thoracic surgery and professor of surgery at Harvard Medical School, Dr. Bueno is a National Cancer Institute-funded investigator who combines translational research with a general thoracic surgery practice.
Jules Fried, CEO, Vasogenesis LLC
Jules is a serial entrepreneur, co-founder, and Chief Executive officer of Vasogenesis LLC, a clinical stage drug company repurposing an off-patent biologic to treat vascular disease.
Michael D'Amore, PhamD, MBA, Sr. Medical Science Liaison, Genentech
At Genentech Michael cultivates relationships with the scientific and medical community serving as a scientific resource, supporting new drugs and upcoming advances in cancer treatments, and providing input about relevant scientific and clinical data to ensure strong understanding of evolving patient treatment trends.
Scott Frushour, Sr. Principle Engineer, Lung Health, Medtronic
For Medtronic Scott’s, focuses on thoracic disease innovation and the assessment of novel technologies and solutions that aim to improve patient care across the thoracic disease spectrum.
Alan D. Lucas, CEO and Cofounder, Navigation Sciences, Inc.
Navigation is developing novel, Image-guided technology for minimally invasive identification and removal of early stage lung lesions and other soft tissue tumors. The technology, which combines intraoperative imaging with Augmented Reality (AR), promises to improve surgical outcomes and increase operational efficiency.
Randolph Setser, PhD. Senior Staff Scientist, Siemens Healthineers Advanced Therapies
Randy manages research collaborations focused on multi-specialty interventional applications as the team lead for interventional cardiovascular MR and interventional pulmonology applications for Siemens Healthineers.
Pierre R. Theodore, M.D., Vice President Global External Innovation, Johnson and Johnson
As the Vice President of Global External Innovation at Johnson & Johnson Dr. Theodore is responsible to help accelerate novel technologies to advance the standard of care in the management of patients with cancer.
Join this timely program to hear about future focused, clinical insights in the management of thoracic disease.
Who should attend
C-level executives, board members, healthcare providers, venture capital and private equity investors, and anyone who wants a better understanding of opportunities and pitfalls of the collaboration between healthcare professionals, tech companies and patients.
Click here for more details.